Skip to content

Application of opioid-free anesthesia combined with TAP block in laparoscopic gynecological surgery : a prospective, randomized, controlled trial

Application of opioid-free anesthesia combined with TAP block in laparoscopic gynecological surgery : a prospective, randomized, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081282
Enrollment
Unknown
Registered
2024-02-28
Start date
2022-07-04
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing laparoscopic gynecological surgery

Interventions

Opioid-free anesthesia group (OFA group):Anesthesia induction and maintenance with opioid-free drugs
Opioid anesthesia group (OA group):Anesthesia induction and maintenance with opioid drugs

Sponsors

Fujian Medical University Affiliated Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Female patients undergoing elective laparoscopic gynecological surgery (including hysterectomy, myomectomy, oophorectomy, salpingectomy, cystectomy); (2) 18-65 years old; (3) Body mass index (BMI) 18.5-29.9 kg/m²; (4) Preoperative ASA grade I-?; (5) Normal liver and kidney function; (6) Mentally normal, can correctly understand the numerical rating scale (NRS) score, assess the degree of pain; (7) Patients informed consent.

Exclusion criteria

Exclusion criteria: ( 1 ) Patients with a history of asthma, diabetes, brain diseases ( such as epilepsy, increased intracranial pressure, brain tumors, previous cerebral infarction, cerebral hemorrhage, etc. ) and a history of major surgery ; ( 2 ) Patients with sinus bradycardia, atrioventricular and intraventricular or sinoatrial block, ventricular premature beats, atrial fibrillation, supraventricular or ventricular tachycardia, unstable angina, valvular disease and previous myocardial infarction and poorly controlled hypertension ; ( 3 ) pregnant or lactating women ; ( 4 ) Patients with abnormal coagulation function ; ( 5 ) patients with previous gastrointestinal bleeding or gastroduodenal ulcer ; ( 6 ) Patients with drug allergy and nerve block contraindications involved in the trial ; ( 7 ) patients with chronic pain or long-term use of sedatives or analgesics ; ( 8 ) Patients with glaucoma, long-term use of ß-blockers and heart rate less than 50 beats / min.

Design outcomes

Primary

MeasureTime frame
PONV;post-operational pain;Postoperative gastrointestinal function recovery time;

Secondary

MeasureTime frame
Ramsay sedation score;recovery time;The first time of get out of bed after operation;hospital stay after operation;Drug use before induction and during operation;Postoperative analgesic and antiemetic consumption;The first postoperative analgesia time;Retention time in resuscitation room; heart rate; systolic blood pressure;diastolic blood pressure,;mean arterial pressure ;postoperative adverse reaction;

Countries

China

Contacts

Public ContactLin Pengtao

Fujian Medical University Affiliated Union Hospital

pengtaolin1993@163.com+86 133 6591 0919

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026